首页> 外文会议>IEEE International Symposium on Biomedical Imaging >Convolutional neural networks for predicting molecular profiles of non-small cell lung cancer
【24h】

Convolutional neural networks for predicting molecular profiles of non-small cell lung cancer

机译:卷积神经网络预测非小细胞肺癌的分子谱

获取原文

摘要

Quantitative imaging biomarkers identification has become a powerful tool for predictive diagnosis given increasingly available clinical imaging data. In parallel, molecular profiles have been well documented in non-small cell lung cancers (NSCLCs). However, there has been limited studies on leveraging the two major sources for improving lung cancer computer-aided diagnosis. In this paper, we investigate the problem of predicting molecular profiles with CT imaging arrays in NSCLC. In particular, we formulate a discriminative convolutional neural network to learn deep features for predicting epidermal growth factor receptor (EGFR) mutation states that are associated with cancer cell growth. We evaluated our approach on two independent datasets including a discovery set with 595 patients (Datset1) and a validation set with 89 patients (Dataset2). Extensive experimental results demonstrated that the learned CNN-based features are effective in predicting EGFR mutation states (AUC=0.828, ACC=76.16%) on Dataset1, and it further demonstrated generalized predictive performance (AUC=0.668, ACC=67.55%) on Dataset2.
机译:鉴于越来越多的可用临床成像数据,定量成像生物标记物的识别已成为预测诊断的有力工具。同时,在非小细胞肺癌(NSCLC)中,分子谱已得到充分证明。但是,关于利用两种主要来源改善肺癌计算机辅助诊断的研究很少。在本文中,我们研究了在NSCLC中用CT成像阵列预测分子谱的问题。特别是,我们制定了判别式卷积神经网络,以学习用于预测与癌细胞生长相关的表皮生长因子受体(EGFR)突变状态的深层特征。我们在两个独立的数据集上评估了我们的方法,包括595位患者的发现集(Datset1)和89位患者的验证集(Dataset2)。大量实验结果表明,基于CNN的学习特征可有效预测Dataset1上的EGFR突变状态(AUC = 0.828,ACC = 76.16 \%),并进一步证明了广义的预测性能(AUC = 0.668,ACC = 67.55 \%)在Dataset2上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号